Table 2a.
Controls |
L-TLE |
R-TLE |
ANOVA |
|||||||
---|---|---|---|---|---|---|---|---|---|---|
M | SD | M | SD | M | SD | F | P | partial η2 | ||
Uncinate FA | RH | 0.37451 | 0.0207 | 0.3520 | 0.0184 | 0.3659 | 0.0352 | 4.12 | .021 | 0.124 |
LH | 0.39061 | 0.0246 | 0.3482r | 0.0294 | 0.3721 | 0.0303 | 11.66 | .000 | 0.287 | |
Arcuate FA | RH | 0.41761 | 0.0219 | 0.3913r | 0.0324 | 0.4179 | 0.0290 | 5.52 | .006 | 0.160 |
LH | 0.43151 | 0.0189 | 0.3942r | 0.0373 | 0.4241 | 0.0278 | 9.60 | .000 | 0.249 | |
IFOFFA | RH | 0.41511 | 0.0199 | 0.3832r | 0.0253 | 0.4062 | 0.0327 | 8.18 | .001 | 0.220 |
LH | 0.42511 | 0.0197 | 0.3802r | 0.0360 | 0.4125 | 0.0307 | 12.98 | .000 | 0.309 | |
Cingulum FA | RH | 0.39661 | 0.0360 | 0.3483 | 0.0411 | 0.3779 | 0.0342 | 8.61 | .001 | 0.229 |
LH | 0.41661 | 0.0487 | 0.3743 | 0.0420 | 0.4091 | 0.0508 | 3.72 | .030 | 0.114 | |
TMT-B | 11.5331 | 2.240 | 8.818 | 2.136 | 9.857 | 1.952 | ||||
% impaired* | 31% | 20% | χ2=0.34; p=.56 | |||||||
VF Switching | 12.0661,r | 2.033 | 7.545 | 3.615 | 9.143 | 3.024 | ||||
% impaired* | 42% | 30% | χ2=0.32; p=.57 |
Pairwise comparison to left TLE significant (p<.025).
Tairwise comparison to right TLE significant (p<.025).
Impairment defined clinically as age-scaled score <7.